SCHEMBL18214863

SCHEMBL18214863

COC(=O)c1cc2n(n1)CC(C)CN2C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.35
ALDH1A1 P00352 5/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
NR1H2 P55055 2/20 0.33
CYP2C9 P11712 1/20 0.33
UCHL1 P09936 1/20 0.32
USP30 Q70CQ3 1/20 0.32
PKM P14618 1/20 0.32
PDE4B Q07343 2/20 0.32
PDE4A P27815 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
KDM4E B2RXH2 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169996 0.83 ALDH1A1 (0.42) PLATALDH1A1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL20852262 0.81 PLAT (0.33) PLATHDAC1HDAC6GPR119NR1H2
SCHEMBL22102668 0.81 GRM5 (0.42) ALDH1A1CYP1A2CYP2C19SMN1; SMN2HDAC1
SCHEMBL24439439 0.74 GPR119 (0.34) GPR119USP30
SCHEMBL26429572 0.73 NR1H2 (0.37) CYP1A2CYP2C19HDAC1MEN1KMT2A
SCHEMBL18618901 0.70 CHRM2 (0.38) CYP1A2CYP2C19GPR119NR1H2PDE4B
SCHEMBL170000 0.69 ESR2 (0.36) ALDH1A1SMN1; SMN2HDAC1HDAC6GPR119
SCHEMBL25594892 0.69 ESR2 (0.36) ALDH1A1SMN1; SMN2HDAC1HDAC6GPR119
SCHEMBL18593220 0.69 CHRM2 (0.38) CYP1A2CYP2C19GPR119NR1H2KDM4E
SCHEMBL18593216 0.69 CHRM2 (0.38) CYP1A2CYP2C19HDAC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650371-B2 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity SHIONOGI & CO., LTD. (JP) 2017-05-16 US disclosed
US-20160326158-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY SHIONOGI & CO (JP) 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326158-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY BACE1, BACE2, APP PLAT 3711/4885ALDH1A1 2852/4885CYP1A2 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.